Connect your AI

Arcus Biosciences RCUS Debt Instrument - Effective Interest Rate

Debt Instrument - Effective Interest Rate at other companies

Heritage FinancialHFWA

5.5%-0.6pp

HRO

HarrowHROW

9.2%-1.5pp

CitigroupC

4.4%0.0pp

Service Corporation InternationalSCI

5.4%-1.0pp

Essential UtilitiesWTRG

4.1%+0.1pp

PaccarPCAR

12.2%+0.7pp

Other financials

Income statement

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

Market cap$3.62B+226%

Enterprise value$3.53B+275%

P/S15.4×+7.5×

Profitability

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentInterestRateEffectivePercentage.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's debt instrument - effective interest rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Arcus Biosciences's debt instrument - effective interest rate?: Arcus Biosciences (RCUS) reported debt instrument - effective interest rate of 12.9% in Q4 2025.